Cocrystal Pharma (COCP)
(Delayed Data from NSDQ)
$1.98 USD
+0.09 (4.76%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $1.93 -0.05 (-2.53%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.53 |
Last EPS Surprise | -3.92% |
ABR | 1.00 |
Earnings ESP
|
-3.01% |
---|---|
Current Year | -1.89 |
Next Year | -2.21 |
EPS (TTM) | -1.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.58 | -1.89 | -2.21 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -0.57 | -0.57 | -2.12 | -2.54 |
High Estimate | -0.50 | -0.55 | -1.67 | -1.64 |
Low Estimate | -0.59 | -0.62 | -2.12 | -2.54 |
Year ago EPS | -0.41 | -0.44 | -1.87 | -1.89 |
Year over Year Growth Est. | -34.15% | -31.82% | -1.07% | -16.58% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.58 | -1.89 | -2.21 |
7 Days Ago | -0.55 | -0.58 | -1.90 | -2.21 |
30 Days Ago | -0.55 | -0.59 | -2.02 | -2.04 |
60 Days Ago | -0.55 | -0.59 | -2.02 | -2.04 |
90 Days Ago | -0.55 | -0.59 | -2.02 | -2.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.57 | -0.57 | -1.90 | -2.54 |
Zacks Consensus Estimate | -0.55 | -0.58 | -1.89 | -2.21 |
Earnings ESP | -3.01% | 1.72% | -0.09% | -15.10% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.53 | -0.39 | -0.44 | -0.41 | NA |
Estimate | -0.51 | -0.54 | -0.57 | -0.47 | NA |
Difference | -0.02 | 0.15 | 0.13 | 0.06 | 0.08 |
Surprise | -3.92% | 27.78% | 22.81% | 12.77% | 14.86% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more